Schonberg David L, McTigue Dana M
The Neuroscience Graduate Studies Program, The Ohio State University, Columbus, OH, USA.
Exp Neurol. 2009 Jul;218(1):64-74. doi: 10.1016/j.expneurol.2009.04.005. Epub 2009 Apr 15.
Progenitor proliferation and differentiation are necessary for oligodendrocyte replacement. Previously, we showed that intraspinal activation of microglia and macrophages with the TLR4 agonist lipopolysaccharide (LPS) induced robust oligodendrocyte genesis. In this study we investigated whether this process involves iron since LPS can alter macrophage regulation of iron and its storage protein ferritin, and oligodendrocytes require iron for proper development and myelination. Further, activated macrophages can sequester and release iron and ferritin. We first examined whether iron or ferritin was present following LPS microinjection. Using Perl's stain, we noted a slight increase in iron at 1d, and peak iron levels 3d post-injection coincident with maximal macrophage activation. Ferritin+ cells were prevalent by 3d and included macrophages and NG2 cells (putative oligodendrocyte progenitors). At 7d, ferritin was mainly expressed by new oligodendrocytes prevalent throughout the lesions. Because of the timing and distribution of iron and ferritin after LPS, we next used an iron chelator to test whether free iron was necessary for maximal LPS-induced oligodendrocyte genesis. Chelating iron by Deferasirox (Exjade) after LPS microinjection significantly reduced the number of proliferating NG2 cells and new oligodendrocytes. Of the remaining oligodendrocytes, there was a 2-fold decrease in those expressing ferritin, revealing that the number of oligodendrocytes with high iron stores was reduced. Collectively, these results establish that iron accumulates after intraspinal TLR4 activation and is required for maximal TLR4-induced oligodendrogenesis. Since TLR4 agonists are abundant in CNS injury/disease sites, these results suggest that iron may be essential for macrophage/oligodendrocyte communication and adult glial replacement.
祖细胞的增殖和分化对于少突胶质细胞的替代是必要的。此前,我们发现用Toll样受体4(TLR4)激动剂脂多糖(LPS)激活脊髓内的小胶质细胞和巨噬细胞可诱导强大的少突胶质细胞生成。在本研究中,我们调查了这一过程是否涉及铁,因为LPS可改变巨噬细胞对铁及其储存蛋白铁蛋白的调节,并且少突胶质细胞的正常发育和髓鞘形成需要铁。此外,活化的巨噬细胞可以螯合和释放铁及铁蛋白。我们首先检查了LPS微量注射后是否存在铁或铁蛋白。使用Perl染色,我们注意到注射后1天铁略有增加,注射后3天铁水平达到峰值,这与巨噬细胞的最大激活相一致。铁蛋白阳性细胞在3天时普遍存在,包括巨噬细胞和NG2细胞(假定的少突胶质细胞祖细胞)。在7天时,铁蛋白主要由遍布病变区域的新生少突胶质细胞表达。由于LPS后铁和铁蛋白的时间和分布情况,我们接下来使用铁螯合剂来测试游离铁对于最大程度的LPS诱导的少突胶质细胞生成是否必要。LPS微量注射后用去铁胺(Exjade)螯合铁可显著减少增殖的NG2细胞和新生少突胶质细胞的数量。在剩余的少突胶质细胞中,表达铁蛋白的细胞减少了2倍,这表明高铁储存量的少突胶质细胞数量减少。总体而言,这些结果表明脊髓内TLR4激活后铁会积累,并且是最大程度的TLR4诱导的少突胶质细胞生成所必需的。由于TLR4激动剂在中枢神经系统损伤/疾病部位大量存在,这些结果表明铁可能对于巨噬细胞/少突胶质细胞通讯和成年神经胶质细胞替代至关重要。